Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Anticoagulation (1)
- Ascites (1)
- Autoimmune hepatitis (1)
- Bisacodyl (1)
- Budesonide (1)
-
- Cirrhosis (1)
- Constipation (1)
- Cryptogenic cirrhosis (1)
- Hepatology (1)
- Interventional radiology (1)
- PVT (1)
- Pancreatic cancer (1)
- Portal hypertension (1)
- Portal vein thrombosis (1)
- Prednisone (1)
- Radiology (1)
- Steroids (1)
- TIPS (1)
- Transjugular intrahepatic portosystemic shunt (1)
- Variceal bleeding (1)
- Varices (1)
Articles 1 - 3 of 3
Full-Text Articles in Medicine and Health Sciences
Oral Budesonide Is An Effective Alternative To Prednisone For Treatment Of Autoimmune Hepatitis, Natanie J. Anilovich
Oral Budesonide Is An Effective Alternative To Prednisone For Treatment Of Autoimmune Hepatitis, Natanie J. Anilovich
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report using:
Manns MP, Woynarowski M, Kreisel W, et al. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology. 2010;139(4):1198-1206. https://doi.org/10.1053/j.gastro.2010.06.046
for a patient with autoimmune hepatitis developing septic arthritis secondary to prednisone therapy.
Oral Bisacodyl Is Effective And Safe For Short Term Treatment Of Chronic Constipation, Akanksha Vaishnav
Oral Bisacodyl Is Effective And Safe For Short Term Treatment Of Chronic Constipation, Akanksha Vaishnav
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report using
Kamm MA, Mueller-Lissner S, Wald A, Richter E, Swallow R, Gessner U. Oral bisacodyl is effective and well-tolerated in patients with chronic constipation. Clin Gastroenterol Hepatol. 2011;9(7):577-583. https://doi.org/10.1016/j.cgh.2011.03.026
to evaluate potential long term treatment with oral Bisacodyl in a patient with a history of chronic constipation and recent non-surgical treatment of ischemic colitis.
Interventional Treatment With The Transjugular Intrahepatic Portosystemic Shunt (Tips) Procedure May Offer A Preferable Alternative To Systemic Anticoagulation In Patients With Cirrhosis And Portal Vein Thrombosis, Molly N. Pantelic
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report appraising:
Wang Z, Jiang MS, Zhang HL, et al. Is post-tips anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis? A randomized controlled trial. Radiology. 2016;279(3):943-951. https://doi.org/10.1148/radiol.2015150369
for a patient with cryptogenic cirrhosis, gastroesophageal varices, pancreatic cancer, and portal vein thrombosis.